This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. Bogousslavsky, MD
Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Arch Neurol. 1985;42(11):1033-1034.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Calandre et al¹ reported very interesting findings in their study of anticoagulant treatment in cerebral embolism secondary to RHD. Their conclusion that early anticoagulation should be delayed in certain patients seems wise and is confirmed by other recent studies.^2,3 However, their comments on intracerebral bleeding as a complication of anticoagulant therapy is a bit obscured by the fact that they discussed "hemorrhagic infarcts" without clearly differentiating true hemorrhagic infarction (HI: mottled, hazy, gyriform appearance on CT scan) from intracerebral hematoma within an infarct (ICHI: more hyperdense and well demarcated), with regard to anticoagulant therapy and clinical course. They described seven patients with intracerebral bleeding, which was "irregularly limited and scattered" in three patients (HI?) or "took the shape of a homogeneous parenchymatous hematoma" in four patients (probably ICHI). Three of these patients were receiving anticoagulant therapy and four were not, but we do not know . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?